Mayo Clinic home page [logo]

Search

  • Print
  • Adjust type size:
  • Font size down
  • Font size up

MayoClinic.com Looks at the Numbers Behind Falling Breast Cancer Rates

A drop in hormone therapy use is one reason but it may not tell the whole story

Tuesday, June 12, 2007

ROCHESTER, Minn. — A new feature on MayoClinic.com provides context and answers questions about the connection between HRT and breast cancer rates raised by a recent study in the New England Journal of Medicine, which reported a 9 percent drop in breast cancer rates from 2001 to 2004 among women age 50 and older.

Researchers point to a major drop in women's use of hormone replacement therapy (HRT) as the likely reason for the decline in breast cancer rates. The sharpest decline — 7 percent — came in 2003. That's the year after a major national study of a combination hormone replacement therapy found the treatment increased the risk of breast cancer and heart disease. Many women were advised to stop taking HRT.

Like many medical discoveries, this new study answers some questions and raises several more. The new MayoClinic.com feature provides detailed answers to questions like:

Are researchers certain that the reduction in HRT is the reason for the decline in breast cancer rates?

It's probably too soon to be certain, and there's probably more than one reason for the decline. Estrogen, the main hormone replaced in HRT, is a growth simulator. It could be that some breast cancers linked to HRT are still occurring but just not evident because they are growing more slowly. More long-term follow-up is needed.

What other factors could contribute to the study results?

Some reports released between 2000 and 2003 questioned the value of mammogram screening, and mammography rates declined. Medications or medical treatments could play a role, too. For example, another study showed that calcium is related to a modest decrease in breast cancer rates. Women have been increasing the amount of calcium in their diets.

How much did the rate of breast cancer actually decline?

Media stories reported varying numbers about the decline in breast cancer incidence, up to 15 percent. That higher rate was for a specific subset of women in the study and doesn't accurately represent the overall decline in breast cancer rates.

Does the drop in breast cancer incidence mean no one should use hormone replacement therapy?

HRT is still an option for women with moderate to severe menopause symptoms. Further study is needed to refine recommendations so women can make informed decisions.

About MayoClinic.com

Launched in 1995 and now visited by millions of users a month, this award-winning consumer Web site offers health information, self-improvement and disease management tools to empower people to manage their health. Produced by a team of Web professionals and medical experts working side by side, MayoClinic.com gives users access to the experience and knowledge of the more than 2,000 physicians and scientists of Mayo Clinic. MayoClinic.com offers users intuitive, easy access tools such as "Symptom Checker" and "First-Aid Guide" for fast answers about health conditions ranging from common to complex; as well as more in-depth sections on over 25 common diseases and conditions, a wealth of healthy living articles, videos, animations and features such as "Ask a Specialist" and "Drug Watch." Users can sign up for a free weekly e-newsletter, "Housecall," which provides the latest health information from Mayo Clinic. For more information, visit www.mayoclinic.com.

###

To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. MayoClinic.com is available as a resource for your health stories.

Contact Information

For more information, contact:

Ginger Plumbo
507-284-5005 (days)
507-284-2511 (evenings)
newsbureau@mayo.edu

Patient & Visitor Guide

Learn more about becoming a patient at Mayo Clinic in the Patient & Visitor Guide.

Terms of Use and Information Applicable to this Site
Copyright ©2001-2008 Mayo Foundation for Medical Education and Research. All Rights Reserved.

.